Skip to main content
Wissam Jaber, MD, Cardiology, Atlanta, GA

WissamAJaberMD

Cardiology Atlanta, GA

Interventional Cardiology

Cath Lab Director, Emory University Hospital Interventional Cardiology Fellowship Director

Dr. Jaber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jaber's full profile

Already have an account?

  • Office

    1364 Clifton Rd
    F606
    Atlanta, GA 30322
    Phone+1 404-727-7040

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2007 - 2008
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2004 - 2007
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2001 - 2004
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 2000

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2011 - 2025
  • AZ State Medical License
    AZ State Medical License 2015 - 2020
  • PA State Medical License
    PA State Medical License 2015 - 2016
  • IA State Medical License
    IA State Medical License 2007 - 2014
  • NC State Medical License
    NC State Medical License 2001 - 2004
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Chronic Total Occlusion Intervention  
    Wissam Jaber, MD, ScienceDirect

Press Mentions

  • PEERLESS: LBMT vs. CDT in Patients at Intermediate Risk of PE
    PEERLESS: LBMT vs. CDT in Patients at Intermediate Risk of PEOctober 29th, 2024
  • PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
    PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary EmbolismOctober 29th, 2024
  • PEERLESS RCT Compares Large-Bore Mechanical Thrombectomy to CDT for Intermediate-Risk PE
    PEERLESS RCT Compares Large-Bore Mechanical Thrombectomy to CDT for Intermediate-Risk PEOctober 29th, 2024
  • Join now to see all

Professional Memberships

Other Languages

  • French, Arabic